Study Finds Link Between Antidepressant Use and Type 2 Diabetes in Youth
October 20, 2017
Current use of serotonin reuptake inhibitors among children and adolescents was associated with a nearly two-fold increased risk of developing type 2 diabetes.
October 20, 2017
Current use of serotonin reuptake inhibitors among children and adolescents was associated with a nearly two-fold increased risk of developing type 2 diabetes.
September 20, 2016
Prescription stimulant use among privately insured adults, particularly women, outpaced use among children and adolescents from 2010 to 2014.
March 10, 2016
International research team, including the School of Pharmacy’s Dr. Julie Zito, publishes new study examining antidepressant prescription rates for individuals ages 0-19 years.
March 3, 2015
Study led by PHSR faculty member shows that 31 states have implemented prior authorization policies for atypical antipsychotic prescribing.
November 12, 2014
Four students from the School’s PHSR PhD Program receive the Arthur Schwartz Memorial Scholarship and Donald O. Fedder Memorial Fellowship in recognition of their superior academic performance.
May 2, 2014
Dr. William Cooper delivers inaugural lecture spotlighting the field of pharmacoepidemiology.
January 10, 2014
Inspiring reflection from Julie Zito, BSPharm, PhD, professor in the Department of Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy.
March 15, 2013
More benefit/risk information is needed in community care efforts, says School of Pharmacy researcher.
December 7, 2012
The University of Maryland Center of Excellence in Regulatory Science and Innovation (UM-CERSI) recently awarded two Innovation Awards and two Innovations in Minority Health Awards to recognize pioneering research initiatives in regulatory science.
October 21, 2009
University of Maryland School of Pharmacy professor welcomes guidelines to ensure better child safety and reduce the risk of inappropriate prescriptions.